摘要
目的:观察健脾活血利水法治疗中心性浆液性脉络膜视网膜病变(简称中浆)的临床疗效。方法:将40例中浆患者随机分成2组,治疗组和西药组各20例,治疗组给予参苓白术散合生蒲黄汤加减,水煎服,每日1剂,西药组给予西医常规治疗,疗程14d,随访1年。结果:治疗组痊愈率总有效率95%,西药组总有效率80%。经统计学分析,两组疗效差异有统计学意义(P<0.05)。结论:健脾活血利水疗法治疗中浆病优于单纯西医治疗。
Objectives： To observe the curative effect of tonifying the spleen, activating blood circulation and alleviating water retention therapy in central serous chorioretinopathy. Methods： 40 cases with central serous chorioretinopathy were randomly divided into two groups： the treatment group （20 cases） and the control group （20 cases）. The treatment group received shen-ling-bai-zhu powder combining with sheng-pu-huang decoction orally once a day, the control group was treated with routine western medicine ac- cordingly. The course of treatment was 14 days, and the patients were followed-up for 1 year. Results ： The cure rate and total effec- tive rate of the treatment group was 95%, the total effective rate of the control group was 80%. There is significant difference between the two groups （ P 〈 0. 05 ）. Conclusion ： Using tonifying the spleen, activating blood circulation and alleviating water retention therapy to treat the central serous chorioretinopathy is superior to pure western medicine therapy.
出处
《成都中医药大学学报》
2014年第2期50-52,共3页
Journal of Chengdu University of Traditional Chinese Medicine
基金
成都市科技计划项目(编号:11DXYB229SF)
四川省科技支撑项目(编号:2012SZ0185)
四川省中医药管理局临床诊疗方案研究科研项目(编号:CKY2010002
合同号:2010-14)
成都中医药大学附属医院科技发展基金项目(编号:2009-D-YY-09)
成都中医药大学附属医院重点学科中医口腔科学基金(编号:P2013019)
关键词
健脾活血利水
中心性浆液性脉络膜视网膜病变
临床观察
Tonifying the spleen
activating blood circulation and alleviating water retention central serous chorioretinopathy
clinical research
